COVID-19 continues to wreak havoc on the global economy, and the healthcare industry has been tested and upended like never before. What steps are healthcare companies and investors taking to preserve value and evaluate opportunities in the current landscape? This virtual conference features 10+ leading advisors, bankers and investors across the healthcare industry who will address two primary issues:
- Healthcare company executives and owners: what strategies should you employ right now to help sustain operations and position yourself for long-term success?
- Healthcare investors: what business and legal issues should you consider when evaluating an investment opportunity?
AGENDA AND SPEAKERS
OPENING REMARKS
- Speaker: Ira Coleman, Chairman, McDermott Will & Emery
COVID-19 IMPACT AND THE ANTICIPATED ROAD TO RECOVERY
- Speaker: Jeff Woods, Managing Director, U.S. Healthcare Practice, EY-Parthenon
THE STATE OF THE HEALTHCARE INDUSTRY
As a healthcare provider or company, what should you do to preserve value, ensure continued operations, negotiate with key stakeholders and evaluate potential financing alternatives or transactions? This panel of leading advisors and bankers, deeply rooted in health business operations across a variety of specialities, will share their observations and effective strategies.
- Moderator: Felicia Perlman, Global Co-Head of Restructuring & Insolvency, McDermott Will & Emery
- Speakers
ART OF THE DEAL DURING COVID-19
What do leading investors and advisors see as the short-term and long-term prognosis of buying and selling in the current market? This panel will provide guidance on how to find opportunities and execute deals, including key considerations in evaluating buy-side opportunities and measuring and protecting against downside risk.
- Moderator: Fred Levenson, Global Co-Head of Private Equity, McDermott Will & Emery
- Speakers
- Mark Francis, Managing Director and Head of the Healthcare Group, Houlihan Lokey
- Brad Giordano, Partner, McDermott Will & Emery
- Peter Kaufman, President and Head of Restructuring and Distressed M&A, Gordian Group
CLOSING REMARKS
Speaker: Jerry Sokol, Partner, McDermott Will & Emery
